Study of BW-50218 in Healthy Participants
Recruiting
Phase 1
Interventional Study
Healthy Participants Study
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Shanghai Argo Biopharmaceutical Co., Ltd. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Phase 1, Single Ascending Dose Study of Subcutaneous BW-50218 in Healthy Participants
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Capable of providing written informed consent and complying with all study procedures for the duration of the study.
* Body weight and body mass index (BMI) within a range considered appropriate for study participation by the investigator.
* Female participants must be non-pre…
Contacts